TOX3 drives hepatocellular carcinoma progression by suppressing the p53-p21-Rb pathway
Shaoping She(Peking University), Hongsong Chen(Chinese Academy of Sciences), Weijia Liao(Guilin Medical University), Ran Fei(Peking University), Jiaxing Fan(Shandong University), Liying Ren(Peking University), Xue Zhang(Peking University), Dongbo Chen(Diponegoro University), Yao Yang(Peking University), Qiongxuan Fang(Peking University)
Cited by 0
Related Papers
New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily
|Pharmacological Research|2020|301
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271
Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development
|Cell stem cell|2012|192
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
|Frontiers in Immunology|2022|122